» Articles » PMID: 22129574

Prevalence of New-onset Insomnia in Patients with Obstructive Sleep Apnoea Syndrome Treated with Nocturnal Ventilatory Support

Overview
Specialty Pulmonary Medicine
Date 2011 Dec 2
PMID 22129574
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: New-onset insomnia (NOI) associated with nocturnal ventilatory support (NVS) is becoming a reality in clinical practice; however there is a lack of data about its prevalence. Our aim was to determine the prevalence of NOI in patients with obstructive sleep apnoea syndrome (OSAS) under NVS and its associated risk factors.

Material And Methods: Descriptive cross-sectional study of 80 patients with OSAS under NVS. We compared two groups, with and without NOI, considering demographic characteristics, disease features, and personality. Patients under anxiolytic and/or antidepressant medication, with a weight loss of 10% or greater, and with restless legs symptoms were excluded.

Results: Median age of patients was 60.0 (interquartile range (IQR) 10.0) years; 82.5% were male. Median initial Epworth Sleepiness Scale (ESS) and apnoea-hypopnoea index (AHI) were 12.5 (IQR 9.0) and 44.1 (IQR 22.4)/hr, respectively. The majority of patients (91.3%) were under auto-adjusting positive airway pressure (APAP). Insomnia at baseline was present in 30% of patients (n=24). Prevalence of NOI was 21.4% (12/56). Initial and/or intermediate insomnia were the most frequent subtypes (n=11). We found a statistically significant negative relation between NOI and pressure on 90% night-time (P(90)) (p=0.040).

Conclusions: OSAS patients under NVS presented a high prevalence of NOI. Patients with NOI presented lower levels of pressure using NVS, compared to the others.

Citing Articles

Stepped care management of insomnia co-occurring with sleep apnea: the AIR study protocol.

Eldridge-Smith E, Manber R, Tsai S, Kushida C, Simmons B, Johnson R Trials. 2022; 23(1):806.

PMID: 36153634 PMC: 9509569. DOI: 10.1186/s13063-022-06753-4.


Comorbid Insomnia and Obstructive Sleep Apnea (COMISA): Current Concepts of Patient Management.

Ragnoli B, Pochetti P, Raie A, Malerba M Int J Environ Res Public Health. 2021; 18(17).

PMID: 34501836 PMC: 8430469. DOI: 10.3390/ijerph18179248.


Evaluating the treatment of obstructive sleep apnea comorbid with insomnia disorder using an incomplete factorial design.

Crawford M, Turner A, Wyatt J, Fogg L, Ong J Contemp Clin Trials. 2016; 47:146-52.

PMID: 26733360 PMC: 4868064. DOI: 10.1016/j.cct.2015.12.017.


Cardiovascular and psychiatric morbidity in obstructive sleep apnea (OSA) with insomnia (sleep apnea plus) versus obstructive sleep apnea without insomnia: a case-control study from a Nationally Representative US sample.

Gupta M, Knapp K PLoS One. 2014; 9(3):e90021.

PMID: 24599301 PMC: 3943798. DOI: 10.1371/journal.pone.0090021.


Insomnia and Obstructive Sleep Apnea.

Ong J, Crawford M Sleep Med Clin. 2013; 8(3):389-398.

PMID: 24015117 PMC: 3763954. DOI: 10.1016/j.jsmc.2013.04.004.